A medical researcher states: 'Our new drug, 'VitalityX,' has been shown to significantly reduce the severity of symptoms in patients with chronic fatigue syndrome. In our clinical trial, 70% of patients receiving VitalityX reported a noticeable improvement, compared to only 30% in the control group.'\n\nWhich of the following, if true, identifies the most serious flaw in the researcher's reasoning?
- AThe patients in the VitalityX group were also encouraged to participate in light exercise.
- BThe study was funded by the company that manufactures VitalityX.
- CThe patients in the VitalityX group were, on average, younger than those in the control group.
- DThe control group received a placebo, but patients were aware they were not receiving the active drug.
Show answer & explanationAnswer & explanation
Correct answer: D. The control group received a placebo, but patients were aware they were not receiving the active drug.
To establish a drug's effectiveness, a double-blind, placebo-controlled trial is ideal. If the control group *knew* they weren't getting the active drug, their reported improvement (or lack thereof) could be heavily influenced by the 'nocebo effect' (negative expectations) or simply a lack of the 'placebo effect' (positive expectations from receiving any treatment), making the comparison with the VitalityX group unreliable. This is a critical flaw in experimental design, undermining the validity of the control group.
Why the other options are wrong
- A. This suggests an alternative cause for improvement in the VitalityX group, which is a flaw, but less fundamental than a compromised control group.
- B. Funding source can suggest bias, but it doesn't inherently invalidate the data or the methodology itself; it's a concern about interpretation, not a direct flaw in the reasoning from the stated results.
- C. Age difference is a confounding variable that could affect symptom severity and response to treatment, but a compromised control group is a more fundamental design flaw.
Compromised Control Group
A flaw in experimental design where the control group is not properly isolated from the independent variable or is subject to biases that invalidate its use as a baseline for comparison.
- Undermines the validity of the experiment.
- Often results from a failure to blind participants or researchers.
- Makes it impossible to confidently attribute observed effects to the treatment.
Memory trick: A broken control group means a broken experiment.